Wednesday, February 09, 2011

Nature looks at Big Pharma

"The pharma industry is deciding its core capabilities are marketing and dealing with regulatory bodies," says Judy Slinn, a business historian at Oxford Brooks University, UK. "Pharma companies will still do development work. They won't do discovery." 


Source

No comments: